FGFR blockade by pemigatinib treats naive and castration resistant prostate cancer. Chiodelli P, Coltrini D, Turati M, Cerasuolo M, et al. Cancer Lett 2021;526:217-224.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chiodelli P, Coltrini D, Turati M, Cerasuolo M, et al. FGFR blockade by pemigatinib treats naive and castration resistant prostate cancer. Cancer Lett 2021;526:217-224.
PMID: 34861311